血液paper

看板NTUMT-91work作者yanche (微涼的妳)時間19年前 (2005/05/23 00:52)推噓9(9推 0噓 1→)

留言10則, 10人參與討論串1/2 (看更多)

我弄丟阿漢克給我的小紙條了可以幫個忙嗎? 麻煩回寄信箱或推文謝謝^^" 以下是題目號碼 1 2 3 4 5 7 12 13 16 17 19 22 23 24 26 28 30 32 37 39 41 47 48 50 52 53 57 58 59 1. Gas6 receptors Ax1, Sky and Mer enhance platelet activation and regulate thrombotic responses. J Throm Haemost. 2005 Feb 23; [Epub ahead of print] 2. Two faces of high-molecular-weight kininogen (HK) in angiogenesis: bradykinin turns it on and cleaved HK (HKa) turns it off. J Throm Haemost. 2005 Feb 23; [Epub ahead of print] 3. Variability in response to aspirin: do we understand the clinical relevance? J Throm Haemost. 2005 Feb 3; [Epub ahead of print] 4. Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress. J Throm Haemost. 2005 Feb 3; [Epub ahead of print] 5. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J Throm Haemost. 2005 Feb;3(2):369-76. 7. Mutation of hydrophobic residues in the factor Va C1 and C2 domains blocks membrane-dependent prothrombin activation. J Throm Haemost. 2005 Feb;3(2):351-4. 12. Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes. J Throm Haemost. 2005 Feb;3(2):254-67. 13. Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication. J Throm Haemost. 2005 Feb;3(2):233-9. 16. The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII--tissue factor complex. J Throm Haemost. 2005 Jan;3(1):112-8. 17. Quantitative high D-dimer value is predictive of pulmonary embolism occurrence independently of clinical score in a well-defined low risk factor population. J Throm Haemost. 2005 Jan;3(1):93-9. 19. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated autoantibodies against platelet-specific receptors. J Throm Haemost. 2005 Jan;3(1):74-8. 22. Pleiotropic functions of plasminogen activator inhibitor-1. J Throm Haemost. 2005 Jan;3(1):35-45. 23. Probing platelet factor 4 alpha-granule targeting. J Throm Haemost. 2004 Dec;2(12):2231-40. 24. The role of ADP and TXA in botrocetin/VWF-induced aggregation of washed platelets. J Throm Haemost. 2004 Dec;2(12):2213-22. 26. The profibrinolytic effect of plasma thrombomodulin in factor XI deficiency and its implications in hemostasis. J Throm Haemost. 2004 Dec;2(12):2200-4. 28. The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis. J Throm Haemost. 2004 Dec;2(12):2118-32. 30. T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects. J Throm Haemost. 2004 Nov;2(11):1908-17. 32. Measurement of von Willebrand factor cleaving protease (ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas. J Throm Haemost. 2004 Sep;2(9):1601-9 37. Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction. Thromb Haemost Haemost. 2005 Mar;93(3):570-7. 39.Variability in clinical laboratory practice in testing for disorders of platelet function: Results of two surveys of the North American Specialized Coagulation Laboratory Association. Thromb Haemost Haemost. 2005 Mar;93(3):549-53. 41. Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with sever haemophilia A. Results of an international clinical investigation. Thromb Haemost Haemost. 2005 Mar;93(3):457-67. 44. A reunification of the US (“NIH”) and International Unit into a single standard for Thrombin. Thromb Haemost Haemost. 2005 Feb;93(2):261-6. 47. Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirin. Thromb Haemost Haemost.. 2005 Jan;93(1):8-16. 48. Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells- potential role of prostaglandin E2. Thromb Haemost Haemost. 2004 Dec;92(6):1358-67. 50. von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women. Thromb Haemost Haemost.. 2004 Dec;92(6):1320-6. 52. Inhibition of plasma kallikrein by C1-inhibitor: role of endothelial cells and the amino-terminal domain of C1-inhibitor. Thromb Haemost. 2004 Dec;92(6):1277-83. 53. Prostaglandin E2 activates channel-mediated calcium entry in human erythrocytes: an indication for a blood clot formation supporting process. Thromb Haemost. 2004 Dec;92(6):1269-72. 57. The factor VII activating protease G511E (Marburg) variant and cardiovascular risk. Thromb Haemost. 2004 Nov;92(5):986-92. 58. Blood coagulation kinetics: high throughput method for real-time reaction monitoring. Thromb Haemost. 2004 Oct;92(4):874-82. 59. Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost. 2004 Sep;92(3):459-66. Review -- ※ 發信站: 批踢踢實業坊(ptt.cc) ◆ From: 140.112.213.48

推

TianKongLan

140.112.226.125 05/23, , 1^F

140.112.226.125 05/23, 1^F

推

BakeMilk

140.112.213.50 05/23, , 2^F

140.112.213.50 05/23, 2^F

推

oceanice

61.59.248.173 05/23, , 3^F

61.59.248.173 05/23, 3^F